Research / BRTX / Fundamental state Inspectable configuration
State dimensions Filing 0001641172-25-023211 General Corporate
Capex intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-888.19% · OPTIONAL · VALID
Revenue growth 85th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
240.40% · CORE · VALID
Gross margin 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
97.12% · CORE · VALID
Operating margin 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-1089.77% · CORE · VALID
R&D intensity 5th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
733.89% · OPTIONAL · VALID
SBC intensity 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
154.54% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 56 states Self-history eligible
Sep 30, 2021 5/6 normalized Level 3 Dec 31, 2021 6/7 normalized Level 3 Mar 31, 2022 6/6 normalized Level 3 Jun 30, 2022 6/6 normalized Level 3 Sep 30, 2022 6/6 normalized Level 3 Dec 31, 2022 6/6 normalized Level 3 Mar 31, 2023 6/6 normalized Level 3 Jun 30, 2023 6/6 normalized Level 3 Sep 30, 2023 6/6 normalized Level 3 Dec 31, 2023 6/6 normalized Level 3 Dec 31, 2023 6/6 normalized Amended as filed Mar 31, 2024 5/5 normalized Level 3 Jun 30, 2024 6/6 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 6/6 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 145.60%
Current 0.00%
Delta -145.60% Cash Generation Increased
Previous -11115.14%
Current -888.19%
Delta 10226.96% Growth Increased
Previous -28.57%
Current 240.40%
Delta 268.98% Margin Increased
Previous 88.36%
Current 97.12%
Delta 8.76% Profitability Increased
Previous -19230.14%
Current -1089.77%
Delta 18140.36% R And D Intensity Decreased
Previous 6857.31%
Current 733.89%
Delta -6123.42% Sbc Intensity Decreased
Previous 8036.50%
Current 154.54%
Delta -7881.97% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.